Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $1.68 Million - $2.95 Million
55,509 Added 301.94%
73,893 $3.66 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $587,736 - $907,618
18,384 New
18,384 $597,000
Q3 2021

Nov 10, 2021

BUY
$90.24 - $124.05 $275,412 - $378,600
3,052 Added 29.81%
13,289 $1.27 Million
Q2 2021

Aug 11, 2021

SELL
$93.66 - $139.27 $180,014 - $267,676
-1,922 Reduced 15.81%
10,237 $1.27 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $213,789 - $284,288
1,834 Added 17.76%
12,159 $1.6 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $1.03 Million - $1.47 Million
10,325 New
10,325 $1.37 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.